🔴 LIVE: The Secrets of ProPicks AI Success Revealed + November’s List FREEWatch Now

CANADA STOCKS-TSX little changed after hitting 10-month high

Published 2016-06-08, 10:52 a/m
© Reuters.  CANADA STOCKS-TSX little changed after hitting 10-month high
CL
-
GOLD
-
BHC
-
GSPTSE
-
DOL
-
SPTTGD
-
SPTTEN
-
SU
-
GG
-

* TSX up 24.21 points, or 0.17 percent, at 14,389.82
* Four of the TSX's 10 main groups higher

OTTAWA, June 8 (Reuters) - Canada's main stock index was
little changed after touching a 10-month high on Wednesday as
gains in commodity prices lifted shares of miners including gold
producers Barrick Gold and Goldcorp .
Shares of retailer Dollarama DOL.TO rose 1.7 percent to
C$94.20 after the company reported a bigger-than-expected rise
in first-quarter profit.
Gold miners .SPTTGD rose 3.5 percent and were the biggest
contributors to the TSX's advance. Gold rallied to a nearly
three-week high as the U.S. dollar was hurt by declining
expectations the Federal Reserve will raise interest rates soon.
GOL/
Goldcorp G.TO rose 2.3 percent to C$23.61 and Barrick Gold
ABX.TO climbed 3.3 percent to C$24.83.
The energy group .SPTTEN , which accounts for about a third
of the weighting of the TSX, retreated from a gain earlier in
the session to lose 0.2 percent.
Shares of Suncor SU.TO fell 2.7 percent to C$35.50 to
weigh on the sector after Raymond James cut its price target on
the stock.
But the sector's declines were capped by a gain in oil
prices as supply disruptions sent U.S. crude CLc1 prices up
1.6 percent to $51.14 a barrel. O/R
The TSX hit a session high of 14,450.91, its highest level
since early August. The index has gained more than 6 percent in
the last four weeks as oil has rebounded to $50 a barrel.
At 10:11 a.m. EDT (1411 GMT), the Toronto Stock Exchange's
S&P/TSX composite index .GSPTSE was up 24.21 points, or 0.17
percent, at 14,389.82.
Of the index's 10 main groups just four were in positive
territory. Advancing issues outnumbered declining ones on the
TSX by 151 to 75, for a 2.01-to-1 ratio on the upside.
On the downside, shares of Valeant Pharmaceuticals (NYSE:VRX)
International VRX.TO lost 3.5 percent to C$30.38 the day after
the company slashed its 2016 outlook.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.